Michael I. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael I. Kim has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Eloise Wood Stanton
Division of Plastic and Reconstructive Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90003, USA
4 shared publications Artur Manasyan
Division of Plastic and Reconstructive Surgery, Los Angeles General Medical Center , Los Angeles, CA 90033
3 shared publicationsDavid A. Daar
Division of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, California, United States
2 shared publicationsEloise W. Stanton
Division of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, California, United States
2 shared publicationsEmma C. Koesters
Division of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, California, United States
2 shared publications- Emma C. Koesters
Division of Plastic and Reconstructive Surgery Keck School of Medicine of University of Southern California Los Angeles California USA
2 shared publications
Latest Publications
- 17 November 2026
- Published by Wiley in Microsurgery
- Vol. 46 (8)
The Timing of Transfusion: Investigating Associations Between Intraoperative Blood Products and Flap Complications in Lower Extremity Free Tissue Reconstruction
Background: Microsurgical free flap reconstruction is pivotal for managing complex lower extremity (LE) defects. Although perioperative blood transfusions are frequently employed to manage anemia and hemodynamic stability, their impact on free flap outcomes, specifically related to timing, remains inadequately understood. This study examines how transfusion timing (preoperative, intraoperative, and postoperative) influences flap complications in LE free flap reconstruction. Methods: A retrospective cohort study was conducted using a prospectively maintained database of patients undergoing LE microsurgical reconstruction at a single academic institution from 2015 to 2024. Inclusion criteria were patients ≥ 18 years with documented perioperative transfusion data and at least 3 months of postoperative follow‐up. Data included patient demographics, comorbidities, injury and operative characteristics, flap details, hemoglobin levels, and detailed transfusion information. Primary outcomes were flap necrosis, flap loss, and any flap‐related complications. Multivariable logistic regression analyses were performed to determine associations between transfusion timing, dose, and outcomes, adjusting for demographic and clinical confounders. Results: Among 133 patients who received free flap LE reconstruction, 48 (36.1%) received perioperative transfusions. Multivariable analysis on propensity matched cohorts revealed intraoperative transfusions were significantly associated with flap loss (OR: 9.70 [1.46–198], p = 0.02), venous congestion (OR: 10.3 [1.20–162], p = 0.03), and surgical site infection (OR: 4.07 [1.06–18.7], p = 0.04). Total number of LE procedures was significantly associated with flap loss (OR: 1.26 [1.04–1.59], p = 0.02), while muscle flaps (OR: 0.07 [0.00–0.92], p = 0.04) and postoperative transfusions (OR: 16.2 [2.35–260], p < 0.01) were significantly associated with venous congestion. Higher doses of intraoperative transfusions were significantly associated with higher rates of flap loss (OR: 2.43 [1.18–8.78], p = 0.01) and venous congestion (OR: 2.42 [1.11–9.09], p = 0.02). Patients receiving perioperative transfusions had lower BMIs, larger wound surface areas, and more LE surgeries during their admission stay. Conclusions: Intraoperative blood transfusions during LE free flap reconstruction were associated with increased flap‐related complications, whereas transfusions administered pre‐ or postoperatively appeared comparatively safer. These findings suggest the importance of optimizing preoperative hemoglobin levels and practicing cautious intraoperative transfusion strategies to improve surgical outcomes.
- 17 November 2026
- Published by Wiley in Microsurgery
- Vol. 46 (8)
The Timing of Transfusion: Investigating Associations Between Intraoperative Blood Products and Flap Complications in Lower Extremity Free Tissue Reconstruction
Background: Microsurgical free flap reconstruction is pivotal for managing complex lower extremity (LE) defects. Although perioperative blood transfusions are frequently employed to manage anemia and hemodynamic stability, their impact on free flap outcomes, specifically related to timing, remains inadequately understood. This study examines how transfusion timing (preoperative, intraoperative, and postoperative) influences flap complications in LE free flap reconstruction. Methods: A retrospective cohort study was conducted using a prospectively maintained database of patients undergoing LE microsurgical reconstruction at a single academic institution from 2015 to 2024. Inclusion criteria were patients ≥ 18 years with documented perioperative transfusion data and at least 3 months of postoperative follow‐up. Data included patient demographics, comorbidities, injury and operative characteristics, flap details, hemoglobin levels, and detailed transfusion information. Primary outcomes were flap necrosis, flap loss, and any flap‐related complications. Multivariable logistic regression analyses were performed to determine associations between transfusion timing, dose, and outcomes, adjusting for demographic and clinical confounders. Results: Among 133 patients who received free flap LE reconstruction, 48 (36.1%) received perioperative transfusions. Multivariable analysis on propensity matched cohorts revealed intraoperative transfusions were significantly associated with flap loss (OR: 9.70 [1.46–198], p = 0.02), venous congestion (OR: 10.3 [1.20–162], p = 0.03), and surgical site infection (OR: 4.07 [1.06–18.7], p = 0.04). Total number of LE procedures was significantly associated with flap loss (OR: 1.26 [1.04–1.59], p = 0.02), while muscle flaps (OR: 0.07 [0.00–0.92], p = 0.04) and postoperative transfusions (OR: 16.2 [2.35–260], p < 0.01) were significantly associated with venous congestion. Higher doses of intraoperative transfusions were significantly associated with higher rates of flap loss (OR: 2.43 [1.18–8.78], p = 0.01) and venous congestion (OR: 2.42 [1.11–9.09], p = 0.02). Patients receiving perioperative transfusions had lower BMIs, larger wound surface areas, and more LE surgeries during their admission stay. Conclusions: Intraoperative blood transfusions during LE free flap reconstruction were associated with increased flap‐related complications, whereas transfusions administered pre‐ or postoperatively appeared comparatively safer. These findings suggest the importance of optimizing preoperative hemoglobin levels and practicing cautious intraoperative transfusion strategies to improve surgical outcomes.
- 5 November 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (09) , 818-824
Rethinking Dangling: Omission of Inpatient Dangle Protocols Shortens Hospital Stay Without Adverse Effects on Lower Extremity Flap Outcomes
Formal dangling protocols are often used after lower extremity free flap reconstruction to acclimate flaps to gravitational stress. However, their clinical benefit remains uncertain. This study evaluates how the inclusion or omission of structured inpatient dangling affects flap outcomes. A retrospective review was conducted of 82 patients who underwent lower extremity free flap reconstruction at a single institution (2015–2024). Patients were grouped based on use of a formal dangling protocol (≥3 consecutive supervised sessions beginning after postoperative day 5) versus no protocol (ad libitum dangling beginning day 3). Outcomes included flap survival, complications, 30-day unplanned reoperation, time to ambulation, and length of stay. Statistical analysis included chi-squared, t-tests, and multivariable regression models. Fifty-three patients adhered to a dangle protocol; 29 did not follow a protocol. Demographics, comorbidities, flap type, and defect characteristics were similar between groups. Flap survival (96.2% vs. 96.6%, p = 0.94), partial necrosis (9.4% vs. 10.3%, p = 0.89), and reoperation rates (3.4% vs. 7.5%, p = 0.46) were comparable. On multivariable analysis, dangle protocol use was not associated with reduced complication risk (OR = 0.95, p = 0.93) but was associated with a 3.0-day longer median hospital stay (p < 0.01). The application of a formal dangling protocol did not affect flap survival but was independently associated with prolonged hospitalization. These findings challenge the necessity of structured regimens and support more patient-tailored postoperative strategies that may accelerate recovery without compromising surgical outcomes.
- 5 November 2025
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 42 (09) , 818-824
Rethinking Dangling: Omission of Inpatient Dangle Protocols Shortens Hospital Stay Without Adverse Effects on Lower Extremity Flap Outcomes
Formal dangling protocols are often used after lower extremity free flap reconstruction to acclimate flaps to gravitational stress. However, their clinical benefit remains uncertain. This study evaluates how the inclusion or omission of structured inpatient dangling affects flap outcomes. A retrospective review was conducted of 82 patients who underwent lower extremity free flap reconstruction at a single institution (2015–2024). Patients were grouped based on use of a formal dangling protocol (≥3 consecutive supervised sessions beginning after postoperative day 5) versus no protocol (ad libitum dangling beginning day 3). Outcomes included flap survival, complications, 30-day unplanned reoperation, time to ambulation, and length of stay. Statistical analysis included chi-squared, t-tests, and multivariable regression models. Fifty-three patients adhered to a dangle protocol; 29 did not follow a protocol. Demographics, comorbidities, flap type, and defect characteristics were similar between groups. Flap survival (96.2% vs. 96.6%, p = 0.94), partial necrosis (9.4% vs. 10.3%, p = 0.89), and reoperation rates (3.4% vs. 7.5%, p = 0.46) were comparable. On multivariable analysis, dangle protocol use was not associated with reduced complication risk (OR = 0.95, p = 0.93) but was associated with a 3.0-day longer median hospital stay (p < 0.01). The application of a formal dangling protocol did not affect flap survival but was independently associated with prolonged hospitalization. These findings challenge the necessity of structured regimens and support more patient-tailored postoperative strategies that may accelerate recovery without compromising surgical outcomes.
- Open Access
- 28 October 2025
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 53 (01) , 117-122
Plastic Surgery Residency Program Instagram Engagement with Prospective Applicants: A Cohort Analysis in the United States
Social media platforms, particularly Instagram, have revolutionized residency recruitment by offering integrated plastic surgery programs innovative avenues to showcase their culture and engage directly with prospective applicants. The COVID-19 pandemic accelerated this digital shift, making virtual interactions essential for evaluating program fit. We identified 88 Accreditation Council for Graduate Medical Education-accredited integrated plastic surgery programs for the academic year 2023 to 2024. Instagram posts from January 1, 2020, to October 26, 2024, were reviewed, focusing on “engagement posts” (e.g., meet-and-greets, question-and-answer [Q&A] sessions, open houses, workshops, conference meet-ups). Programs were stratified into cohorts based on Doximity rankings (Top 20, 21–40, 41–60, and 61–88), geographic region, and program size. All programs maintained active Instagram profiles, collectively sharing 13,719 posts and averaging 32.4 posts per program annually. Among these, 369 (2.7%) were engagement posts, with meet-and-greets accounting for 71.3% of such content. Notably, Top 20 programs posted significantly more frequently (52.6 posts/year) than lower-ranked cohorts (21–40: 35.0, 41–60: 26.8, 61–88: 20.1; p < 0.001) and had a higher engagement post rate (3.9% vs. 2.0–2.7%; p = 0.033). Higher-ranked and larger programs exhibit a more robust Instagram presence with greater emphasis on engagement opportunities, despite these posts comprising only a small fraction of overall content. These findings highlight the potential for optimized social media strategies to enhance digital outreach and improve residency recruitment in an evolving virtual landscape.
- 28 October 2025
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 53 (01) , 117-122
Open AccessPlastic Surgery Residency Program Instagram Engagement with Prospective Applicants: A Cohort Analysis in the United States
Social media platforms, particularly Instagram, have revolutionized residency recruitment by offering integrated plastic surgery programs innovative avenues to showcase their culture and engage directly with prospective applicants. The COVID-19 pandemic accelerated this digital shift, making virtual interactions essential for evaluating program fit. We identified 88 Accreditation Council for Graduate Medical Education-accredited integrated plastic surgery programs for the academic year 2023 to 2024. Instagram posts from January 1, 2020, to October 26, 2024, were reviewed, focusing on “engagement posts” (e.g., meet-and-greets, question-and-answer [Q&A] sessions, open houses, workshops, conference meet-ups). Programs were stratified into cohorts based on Doximity rankings (Top 20, 21–40, 41–60, and 61–88), geographic region, and program size. All programs maintained active Instagram profiles, collectively sharing 13,719 posts and averaging 32.4 posts per program annually. Among these, 369 (2.7%) were engagement posts, with meet-and-greets accounting for 71.3% of such content. Notably, Top 20 programs posted significantly more frequently (52.6 posts/year) than lower-ranked cohorts (21–40: 35.0, 41–60: 26.8, 61–88: 20.1; p < 0.001) and had a higher engagement post rate (3.9% vs. 2.0–2.7%; p = 0.033). Higher-ranked and larger programs exhibit a more robust Instagram presence with greater emphasis on engagement opportunities, despite these posts comprising only a small fraction of overall content. These findings highlight the potential for optimized social media strategies to enhance digital outreach and improve residency recruitment in an evolving virtual landscape.
- 19 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (4) , 725-729
Integrating Addiction Medicine Into Burn Care: Optimizing Pain Management in Stimulant-Positive Patients
Stimulant use poses significant challenges in burn care, complicating pain management and leading to poorer outcomes, including longer hospital stays, higher complication rates, and increased healthcare costs. This study evaluates burn-related outcomes in stimulant-positive patients, as well as tabulates how frequently addiction medicine consultations are used in burn patients with positive stimulant screens. Patients with positive urine toxicology screens for stimulants, including amphetamines and cocaine, were identified. The primary predictor variable was stimulant use, while primary outcomes included length of hospital stay, burn severity, complications, and overall outcomes of care. Out of 3403 burn patients (34% female, 66% male, with a mean age of 39.2 ± 22.8 years), 572 patients (16.8%) had positive urine toxicology screens for stimulants. Stimulant-positive patients had significantly longer hospital stays compared to stimulant-negative patients (17.7 vs. 10.7 days, P < .001), more severe burns (P = .001), and a higher incidence of complications (15.6% vs. 11.5%, P = .006). Despite these risks, only 12.6% (72 patients) of stimulant-positive burn patients received an addiction medicine consultation during their hospitalization. The use of addiction medicine consultations increased over time, rising from 3 consults in 2015 to 42 in 2023. A multidisciplinary approach that includes addiction medicine can help address both the complexities of pain management and substance use, leading to improved patient outcomes. Early involvement of addiction medicine could enhance pain management and recovery, emphasizing the need for more systematic integration of addiction medicine into burn care protocols.
- 19 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (4) , 725-729
Integrating Addiction Medicine Into Burn Care: Optimizing Pain Management in Stimulant-Positive Patients
Stimulant use poses significant challenges in burn care, complicating pain management and leading to poorer outcomes, including longer hospital stays, higher complication rates, and increased healthcare costs. This study evaluates burn-related outcomes in stimulant-positive patients, as well as tabulates how frequently addiction medicine consultations are used in burn patients with positive stimulant screens. Patients with positive urine toxicology screens for stimulants, including amphetamines and cocaine, were identified. The primary predictor variable was stimulant use, while primary outcomes included length of hospital stay, burn severity, complications, and overall outcomes of care. Out of 3403 burn patients (34% female, 66% male, with a mean age of 39.2 ± 22.8 years), 572 patients (16.8%) had positive urine toxicology screens for stimulants. Stimulant-positive patients had significantly longer hospital stays compared to stimulant-negative patients (17.7 vs. 10.7 days, P < .001), more severe burns (P = .001), and a higher incidence of complications (15.6% vs. 11.5%, P = .006). Despite these risks, only 12.6% (72 patients) of stimulant-positive burn patients received an addiction medicine consultation during their hospitalization. The use of addiction medicine consultations increased over time, rising from 3 consults in 2015 to 42 in 2023. A multidisciplinary approach that includes addiction medicine can help address both the complexities of pain management and substance use, leading to improved patient outcomes. Early involvement of addiction medicine could enhance pain management and recovery, emphasizing the need for more systematic integration of addiction medicine into burn care protocols.
- 7 April 2025
- Published by Wiley in Microsurgery
- Vol. 45 (4) , e70059
Free Flap Reconstruction of Abdominal Wall Defects: A Systematic Review and Pooled Analysis
Background: Reconstruction of extensive abdominal wall defects poses significant challenges, often requiring free tissue transfer when traditional methods are inadequate. This review examines the past decade's literature on free flaps for abdominal wall reconstruction to guide decision‐making. Methods: A systematic review following PRISMA guidelines was conducted on July 17, 2024, using PubMed, Cochrane Library, Web of Science, Embase, and Scopus. Studies from 2013 to 2023 involving free flap reconstruction with at least 3 months follow‐up were included. Surgical complications and outcomes were analyzed. Results: Of 2269 articles, 32 met inclusion criteria, involving 104 free flaps. There were no reports of flap loss. The average defect size was 330.0 ± 200.8 cm 2 . Oncologic resection was the leading indication (57%), with the latissimus dorsi flap used most frequently (36%). The most common recipient vessels were the deep inferior epigastric vessels (66.7%). The most common recipient vessels were the deep inferior epigastric vessels (66.7%). Mesh was used in 53% of cases, predominantly in a sublay position. The majority of reconstructions were immediate (52.9%), followed by delayed (31.8%) and staged (15.3%). Complications included partial flap necrosis (5.8%), surgical site infection (5.8%), and hernia development (4.8%). There were no significant differences in outcomes when stratified by reconstruction timing, flap choice, recipient vessels, or mesh characteristics. Infection as the defect etiology independently predicted surgical site infection ( p = 0.03), whereas mesh usage ( p = 0.07) and diabetes ( p = 0.09) trended toward increased infection risk. Donor site complications were minimal. Conclusion: Free flap reconstruction is safe and effective for large abdominal wall defects, with similar outcomes across flap types. Infection as the initial etiology was the strongest predictor of postoperative infection. Further studies are needed to establish guidelines for patient and flap selection.
- 7 April 2025
- Published by Wiley in Microsurgery
- Vol. 45 (4) , e70059
Free Flap Reconstruction of Abdominal Wall Defects: A Systematic Review and Pooled Analysis
Background: Reconstruction of extensive abdominal wall defects poses significant challenges, often requiring free tissue transfer when traditional methods are inadequate. This review examines the past decade's literature on free flaps for abdominal wall reconstruction to guide decision‐making. Methods: A systematic review following PRISMA guidelines was conducted on July 17, 2024, using PubMed, Cochrane Library, Web of Science, Embase, and Scopus. Studies from 2013 to 2023 involving free flap reconstruction with at least 3 months follow‐up were included. Surgical complications and outcomes were analyzed. Results: Of 2269 articles, 32 met inclusion criteria, involving 104 free flaps. There were no reports of flap loss. The average defect size was 330.0 ± 200.8 cm 2 . Oncologic resection was the leading indication (57%), with the latissimus dorsi flap used most frequently (36%). The most common recipient vessels were the deep inferior epigastric vessels (66.7%). The most common recipient vessels were the deep inferior epigastric vessels (66.7%). Mesh was used in 53% of cases, predominantly in a sublay position. The majority of reconstructions were immediate (52.9%), followed by delayed (31.8%) and staged (15.3%). Complications included partial flap necrosis (5.8%), surgical site infection (5.8%), and hernia development (4.8%). There were no significant differences in outcomes when stratified by reconstruction timing, flap choice, recipient vessels, or mesh characteristics. Infection as the defect etiology independently predicted surgical site infection ( p = 0.03), whereas mesh usage ( p = 0.07) and diabetes ( p = 0.09) trended toward increased infection risk. Donor site complications were minimal. Conclusion: Free flap reconstruction is safe and effective for large abdominal wall defects, with similar outcomes across flap types. Infection as the initial etiology was the strongest predictor of postoperative infection. Further studies are needed to establish guidelines for patient and flap selection.
- 6 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 298-306
The 5-factor modified frailty index as a predictor of outcomes in abdominal wall reconstruction
- 6 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 298-306
The 5-factor modified frailty index as a predictor of outcomes in abdominal wall reconstruction
- Open Access
- 2 March 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (1) , 7
Providers’ Perspectives on Communication Barriers with Language-Discordant Patients in the Critical Care Setting: A Systematic Review
Background: Language discordance occurs when the patient and the healthcare provider are not proficient in the same language. Language discordance in the critical care setting is a significant global issue because of its implications in the quality of care and outcomes of patients who do not speak the primary language of the country in which they receive healthcare. Studies show that language-discordant, critically ill patients have increased use of restraints during mechanical ventilation, increased length of stay, and more frequent complications. Communication challenges are magnified in the intensive care unit because of the medical complexity and frequent need for challenging conversations regarding goals of care. To address language-based disparities in critical care, numerous qualitative studies in recent years have attempted to understand the barriers that providers face when caring for language-discordant patients. Our systematic review is the first to analyze this developing body of literature and identify barriers for which solutions must be sought to ensure equitable care. Methods: This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Embase, and Scopus from inception up to 20 February 2024. From among 2150 articles, nine articles were selected, which included eight qualitative studies and one cross-sectional study. Three studies were high quality, five were moderate quality, and one was low quality. Results: We found four major barriers to caring for language-discordant patients in the critical care setting. These included limitations in providers’ knowledge of best practices in professional medical interpreter use, challenges in navigating interpreters’ multiple roles, and limitations with different interpretive modalities and system constraints. These barriers caused clinicians distress due to clinicians’ desire to provide empathic care that respected patients’ autonomy and ensured patients’ safety and understanding. Conclusion: Interventions to increase providers’ knowledge of best practices, integrate interpreters into the critical care team, strategize the use of interpretation modalities, and address system-based barriers are needed to improve the care of language-discordant, critically ill patients worldwide.
- 2 March 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (1) , 7
Open AccessProviders’ Perspectives on Communication Barriers with Language-Discordant Patients in the Critical Care Setting: A Systematic Review
Background: Language discordance occurs when the patient and the healthcare provider are not proficient in the same language. Language discordance in the critical care setting is a significant global issue because of its implications in the quality of care and outcomes of patients who do not speak the primary language of the country in which they receive healthcare. Studies show that language-discordant, critically ill patients have increased use of restraints during mechanical ventilation, increased length of stay, and more frequent complications. Communication challenges are magnified in the intensive care unit because of the medical complexity and frequent need for challenging conversations regarding goals of care. To address language-based disparities in critical care, numerous qualitative studies in recent years have attempted to understand the barriers that providers face when caring for language-discordant patients. Our systematic review is the first to analyze this developing body of literature and identify barriers for which solutions must be sought to ensure equitable care. Methods: This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Embase, and Scopus from inception up to 20 February 2024. From among 2150 articles, nine articles were selected, which included eight qualitative studies and one cross-sectional study. Three studies were high quality, five were moderate quality, and one was low quality. Results: We found four major barriers to caring for language-discordant patients in the critical care setting. These included limitations in providers’ knowledge of best practices in professional medical interpreter use, challenges in navigating interpreters’ multiple roles, and limitations with different interpretive modalities and system constraints. These barriers caused clinicians distress due to clinicians’ desire to provide empathic care that respected patients’ autonomy and ensured patients’ safety and understanding. Conclusion: Interventions to increase providers’ knowledge of best practices, integrate interpreters into the critical care team, strategize the use of interpretation modalities, and address system-based barriers are needed to improve the care of language-discordant, critically ill patients worldwide.
- Open Access
- 26 February 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (3) , 642-645
Ibuprofen is Not Associated With an Elevated Bleeding Risk or Transfusion Requirement in Skin Grafting for Patients With Burn Injuries
Ibuprofen, a non-steroidal anti-inflammatory drug, can increase the risk of bleeding, a significant concern in burn surgery, which often involves substantial blood loss. This study aims to evaluate the safety of ibuprofen use in burn patients undergoing skin grafting. A retrospective case-control chart review was conducted for patients admitted with acute burn injury from January 1, 2024 to July 31, 2024 who underwent skin grafting. The primary outcome variables included perioperative transfusion requirement, bleeding, skin graft failure, and other complications. A total of 53 patients met the inclusion criteria, 24 (45.2%) of whom received scheduled ibuprofen therapy during their hospitalization. The total body surface area affected was 12.3 ± 9.3% for the non-ibuprofen group and 14.3 ± 12.1% for the ibuprofen group (P = .62). A total of 79.3% of patients in the non-ibuprofen group received meshed grafts compared to 79.2% in the ibuprofen group (P = .734). Perioperative transfusion requirements were similar between the 2 cohorts, averaging 4.6 ± 3.1 for the non-ibuprofen group and 3.2 ± 2.8 units of packed red blood cells for the ibuprofen group (P = .207). Skin graft failure (defined as the need for re-grafting) occurred in 6.9% (n = 2) of the non-ibuprofen cohort vs none (n = 0) in the ibuprofen group (P = .112). Postoperative complications did not vary significantly between the 2 groups for seroma (P = .259), hematoma (P = .498), and infection (P = .568). There were no cases of hypersensitivity or gastrointestinal bleeding. There is likely no increased risk of bleeding or skin graft failure in burn injury patients taking ibuprofen, suggesting that these medications may be safe in this context.
- 26 February 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (3) , 642-645
Open AccessIbuprofen is Not Associated With an Elevated Bleeding Risk or Transfusion Requirement in Skin Grafting for Patients With Burn Injuries
Ibuprofen, a non-steroidal anti-inflammatory drug, can increase the risk of bleeding, a significant concern in burn surgery, which often involves substantial blood loss. This study aims to evaluate the safety of ibuprofen use in burn patients undergoing skin grafting. A retrospective case-control chart review was conducted for patients admitted with acute burn injury from January 1, 2024 to July 31, 2024 who underwent skin grafting. The primary outcome variables included perioperative transfusion requirement, bleeding, skin graft failure, and other complications. A total of 53 patients met the inclusion criteria, 24 (45.2%) of whom received scheduled ibuprofen therapy during their hospitalization. The total body surface area affected was 12.3 ± 9.3% for the non-ibuprofen group and 14.3 ± 12.1% for the ibuprofen group (P = .62). A total of 79.3% of patients in the non-ibuprofen group received meshed grafts compared to 79.2% in the ibuprofen group (P = .734). Perioperative transfusion requirements were similar between the 2 cohorts, averaging 4.6 ± 3.1 for the non-ibuprofen group and 3.2 ± 2.8 units of packed red blood cells for the ibuprofen group (P = .207). Skin graft failure (defined as the need for re-grafting) occurred in 6.9% (n = 2) of the non-ibuprofen cohort vs none (n = 0) in the ibuprofen group (P = .112). Postoperative complications did not vary significantly between the 2 groups for seroma (P = .259), hematoma (P = .498), and infection (P = .568). There were no cases of hypersensitivity or gastrointestinal bleeding. There is likely no increased risk of bleeding or skin graft failure in burn injury patients taking ibuprofen, suggesting that these medications may be safe in this context.